Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inducible resistance to vancomycin in Enterococcus faecium D366.

R Williamson1, S Al-Obeid, J H Shlaes

  • 1Laboratoire de Microbiologie Médicale, Université de Paris VI, France.

The Journal of Infectious Diseases
|June 1, 1989
PubMed
Summary

Vancomycin resistance in Enterococcus faecium is inducible, triggered by exposure to the antibiotic. This resistance correlates with the production of a specific cytoplasmic membrane protein that also affects cell lysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combating resistance in a challenging, changing environment.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2007
Same author

Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin.

The Journal of antimicrobial chemotherapy·2007
Same author

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006
Same author

Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006
Same author

Respiratory syncytial virus infection: an emerging or unappreciated infection?

Seminars in respiratory and critical care medicine·2005
Same author

Antibacterial drug discovery: is it all downhill from here?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2004

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Resistance

Background:

  • Enterococcus faecium is a common cause of hospital-acquired infections.
  • Vancomycin is a critical antibiotic for treating infections caused by Gram-positive bacteria.
  • Emergence of vancomycin resistance in E. faecium poses a significant public health threat.

Purpose of the Study:

  • To investigate the inducibility and mechanisms of vancomycin resistance in a clinical isolate of Enterococcus faecium (Strain D366).
  • To identify potential molecular correlates of vancomycin resistance.
  • To understand the functional implications of induced resistance on bacterial physiology.

Main Methods:

  • Exposure of exponential-phase cultures of E. faecium D366 to sub-inhibitory concentrations of vancomycin.

Related Experiment Videos

  • Assessment of growth kinetics and resistance profiles to vancomycin and other glycopeptides.
  • Analysis of protein synthesis using techniques to identify novel proteins.
  • Correlation of protein expression with resistance levels and cellular functions.
  • Main Results:

    • Vancomycin exposure induced a lag phase in growth, which was abolished by pre-exposure.
    • Pre-exposure to vancomycin resulted in cross-resistance to other glycopeptides.
    • A 39.5-kDa cytoplasmic membrane protein was synthesized upon vancomycin exposure.
    • This protein was associated with high-level resistance and altered lytic functions.

    Conclusions:

    • Vancomycin resistance in E. faecium D366 is an inducible phenomenon.
    • The induced resistance is mediated by a 39.5-kDa cytoplasmic membrane protein.
    • This protein plays a role in both vancomycin resistance and the inhibition of normal cell lysis.